NTRA vs MDLN Comparison

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Medline Inc provides medical-surgical products and supply chain solutions for various healthcare settings. Its offerings include med-surg products, including surgical and procedural kits, gloves and protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. It serves hospitals, surgery centers, physician offices, and post-acute care facilities, supporting patient care needs. The company operates in two segments: Medline Brand and Supply Chain Solutions. The company's revenues are generated principally from the sale of its surgical products.